Lucia Minelli

Dr. Lucia Minelli

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
FAFilippo Dell Anno
Filippo Dell Anno
LMLucia Minelli
Lucia Minelli
Giuseppe GigliaGiuseppe Giglia
Giuseppe Giglia
ELElvio Lepri
Elvio Lepri
MMMarta Mechelli
Marta Mechelli
Elisabetta ManualiElisabetta Manuali
Elisabetta Manuali
Splenic lesions are common in dogs and can have important clinical implications due to the risk of rupture causing life-threatening hemorrhage, or, for neoplastic lesions, potential metastatic spread. This retrospective study analyzed 682 canine spleen samples submitted to the Regional Canine Cancer Registry in Umbria, Italy, between 2014 and 2023, aiming to characterize lesion types and explore associations with demographic factors and clinical outcomes. Lesions were classified as neoplastic or non-neoplastic. Non-neoplastic lesions were predominant (54.3%), mainly nodular hyperplasia, hematoma, and congestion, while neoplastic lesions accounted for 45.7%, with hemangiosarcoma (HSA) being the most frequent neoplasm (54.5%), followed by other sarcomas, lymphomas, and rare tumors. The mean age at diagnosis was 10.4 years, and medium-sized dogs living in urban areas were most affected. No significant differences in lesion type were observed between sexes or between purebred and mixed-breed dogs, although purebreds were more represented overall. HSA risk varied by size, sex, and breed, with large dogs and certain pure breeds showing elevated risk. Survival analysis revealed markedly reduced outcomes for dogs with HSA. These findings emphasize the utility of histopathologic diagnosis in guiding clinical management and provide insight into the epidemiology and prognosis of splenic lesions in dogs.

15 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MBMichela Bruschi
Michela Bruschi
SMSofia Masini
Sofia Masini
FPFrancesco Palma
Francesco Palma
YXYang Xiaoqiu
Yang Xiaoqiu
CBCassia Lisboa Braga
Cassia Lisboa Braga
AFAlessandra Fraternale
Alessandra Fraternale
The persistence of P. aeruginosa infections is largely driven by the secretion of several factors during invasion, including the redox-active phenazine pyocyanin (PYO), which promotes biofilm formation and oxidative stress. Biofilms contribute to chronic infections and antibiotic resistance, limiting the efficacy of conventional therapies. We found that a synthetic compound, I-152, a conjugate of N-acetyl-L-cysteine (NAC) and S-acetylcysteamine (also known as S-acetyl-β-mercaptoethylamine; SMEA), effectively restored colistin susceptibility against P. aeruginosa by altering biofilm nanomechanical properties. These perturbations in matrix integrity were associated with I-152’s ability to hinder the phenazine redox cycle, shifting PYO to a reduced state as well as enabling S-conjugate formation. The compound decreased PYO accumulation in bacterial cultures and PYO-generated reactive oxygen species (ROS) in macrophage cells. Together with PYO, LPS is another driver of ROS-dependent inflammatory signaling in the host, which leads to an uncontrolled cytokine response and organ damage, especially in patients with cystic fibrosis. I-152 treatment downregulated the expression of LPS-induced inflammatory cytokines, i.e., IL-6 and TNF-α, in bone marrow-derived macrophages (BMDM) isolated from transgenic CFTR -/- and CFTR +/+ mice. Consistently, I-152 partially counteracted the inflammatory response in the P. aeruginosa LPS-induced acute lung injury murine model. Taken together, these results support I-152 as an adjunctive treatment for P. aeruginosa respiratory infections through a dual mechanism: combating antimicrobial resistance in biofilms and dampening host inflammation in the respiratory system. Highlights: I-152 potentiates colistin activity against P. aeruginosa by compromising the biofilm surface I-152 rewires the pyocyanin (PYO) redox state and forms covalent adducts with it PYO accumulation and PYO-induced ROS generation in macrophages is impaired by I-152 Ex vivo, I-152 dampens excessive pro-inflammatory response to P. aeruginosa LPS in CFTR - / - and CFTR + / + BM-derived macrophages I-152 (140 mg/Kg) attenuates LPS-driven inflammation and lung damage in CFTR + / + mice